Next Article in Journal
Genome Identification and Expression Profiling of the PIN-Formed Gene Family in Phoebe bournei under Abiotic Stresses
Next Article in Special Issue
Dynamic Cytoophidia during Late-Stage Drosophila Oogenesis
Previous Article in Journal
Light Intensity Modulates the Functional Composition of Leaf Metabolite Groups and Phyllosphere Prokaryotic Community in Garden Lettuce (Lactuca sativa L.) Plants at the Vegetative Stage
Previous Article in Special Issue
New Functional Motifs for the Targeted Localization of Proteins to the Nucleolus in Drosophila and Human Cells
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Connecting Hippo Pathway and Cytoophidia in Drosophila Posterior Follicle Cells

1
School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China
2
State Key Laboratory of Cell Biology, Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai 200031, China
3
Sheng Yushou Center of Cell Biology and Immunology, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai 200240, China
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2024, 25(3), 1453; https://doi.org/10.3390/ijms25031453
Submission received: 19 December 2023 / Revised: 18 January 2024 / Accepted: 19 January 2024 / Published: 25 January 2024
(This article belongs to the Special Issue Molecular Genetics of Drosophila Development)

Abstract

:
CTP synthase (CTPS), the rate-limiting enzyme in the de novo synthesis of CTP, assembles into a filamentous structure termed the cytoophidium. The Hippo pathway regulates cell proliferation and apoptosis. The relationship of the nucleotide metabolism with the Hippo pathway is little known. Here, we study the impact of the Hippo pathway on the cytoophidium in Drosophila melanogaster posterior follicle cells (PFCs). We find that the inactivation of the Hippo pathway correlates with reduced cytoophidium length and number within PFCs. During the overexpression of CTPS, the presence of Hippo mutations also reduces the length of cytoophidia in PFCs. In addition, we observe that knocking down CTPS mitigates hpo (Hippo)-associated over-proliferation. In summary, our results suggest that there is a connection between the Hippo pathway and the nucleotide biosynthesis enzyme CTPS in PFCs.

1. Introduction

The nucleotide metabolism plays a crucial role in various cellular processes, including the synthesis of DNA and RNA and the generation of cellular energy. The synthesis of purines and pyrimidines follows two primary pathways: the de novo nucleotide synthesis and the salvage pathway. CTP synthase (CTPS) assumes the role of the rate-limiting enzyme in the de novo synthesis pathway for CTP [1,2]. CTPS exhibits a dynamic equilibrium among monomers, dimers and tetramers [3]. In the presence of a substrate, CTPS presents at a high concentration of the active tetramer type [4]. The activity of CTPS is increased in cancer cells, such as those in liver neoplasia and kidney tumors [5].
In 2010, CTPS was discovered to form filamentous structures, known as cytoophidia [6]. Cytoophidia are highly conserved in various species, including Saccharomyces cerevisiae [7], Schizosaccharomyces pombe [8] and mammalian cells [9]. Furthermore, the formation of cytoophidia is regulated by Myc [10], Ras [11], the mTOR-S6K1 pathway [12,13] and nutritional conditions [14] in the Drosophila melanogaster. Cytoophidia also appear in cancer cells, such as those found in human hepatocellular carcinoma [15].
Cytoophidia are widely distributed during both the larval stage [16] and oogenesis of Drosophila. Within the Drosophila ovaries, cytoophidia are observed in various cell types, including follicle cells, nurse cells and oocytes [17,18,19]. Cytoophidia can be categorized into two distinct classes: micro-cytoophidia, measuring approximately 1–4 μm in length, and macro-cytoophidia, which can extend to up to 30–40 μm [6]. Functionally, cytoophidia serve as scaffolds [20,21,22] and effectively prolong the half-life of CTPS [23]. Considering that CTPS is a rate-limiting enzyme, it is crucial to gain a comprehensive understanding of its regulatory mechanism.
The Hippo pathway was first discovered in Drosophila in 1995 [24,25]. The mutations of the Hippo pathway result in an over-proliferative phenotype. In Drosophila, the core of the Hippo pathway coordinates a series of phosphorylation events that ultimately inhibit the transcriptional coactivator Yorkie (Yki). Initially, the Sterile 20-like kinase Hippo (Hpo) [26] associates with the WW domain scaffolding protein Salvador (Sav) [27] to phosphorylate and activate the DBF family kinase Warts (Wts). Subsequently, the activated Wts interacts with Mob as a tumor suppressor (Mats) [28] to phosphorylate and inhibit Yki [29], creating a 14-3-3 binding site. Yki then binds with the 14-3-3 protein, retaining Yki in the cytoplasm [30].
The Hippo pathway is evolutionarily conserved in mammals [31]. The Hippo pathway controls the expression of downstream genes, including diap1, bantam and cyclin E [32], to regulate proliferation and apoptosis, thereby maintaining tissue size homeostasis [33]. Furthermore, the Hippo pathway is implicated in the regulation of the lipid metabolism and organ regeneration [34]. The dysregulation of the Hippo pathway has been identified in various cancers, such as malignant mesothelioma [35] and prostate adenocarcinoma [36]. A previous study has found that YAP1 increases the glutamine level and enhances de novo nucleotide synthesis in zebrafish [37,38]. The knockdown of YAP/TAZ decreased the expression of CTPS1 in MDA-MB-231 cells [39]. However, the mechanism by which the Hippo pathway regulates nucleotide synthesis remains unknown. Therefore, our study aimed to investigate the connection between the Hippo pathway and cytoophidia.
Using the Drosophila egg chamber as a model [40], we observed that the Hippo pathway and cytoophidium assembly interconnect in posterior follicle cells (PFCs). Mutations in the Hippo pathway result in over-proliferation and Notch accumulation in the PFCs. Hippo pathway mutations reduce the length and number of cytoophidia within the PFCs. In addition, Hippo pathway mutations reduce the length of the cytoophidium, even when CTPS is overexpressed. CTPS knockdown suppresses the over-proliferative phenotype in hpo mutant PFCs. Therefore, our study connects the Hippo pathway and cytoophidia in PFCs.

2. Results

2.1. Hippo Pathway Is Essential for Oocyte Polarity

In Drosophila oogenesis, the establishment of the body axis depends on the polarization of the oocyte [41,42]. The asymmetric distribution of mRNA and proteins within the oocyte plays a pivotal role in determining the anterior–posterior (AP) body axis [43]. For example, gurken (grk) mRNA localizes adjacent to the oocyte nucleus [44], while bicoid (bcd) mRNA is found at the anterior pole [42], and oskar (osk) mRNA is concentrated at the posterior pole [41]. The dysregulation of the Hippo pathway disrupts oocyte migration, leading to the over-proliferation of anterior and posterior follicle cells, as well as the mis-localization of Osk and Staufen (Stau) [45,46].
We used a mosaic analysis with a repressible cell marker (MARCM) technique [47] to generate FRT/FLP mitotic clones of mutated cells with a loss of function (wtsx1) allele of wts. In control egg chambers, the OSK signal was localized in the crescent at the posterior side (Figure 1A,B), while single-layer follicle cells surrounded the germline cells (Figure 1C). The Notch intracellular domain (NICD) signal was observed at the apical part of the follicle cells (Figure 1A,D). The GFP signal indicated that the follicle cells expressed GFP but had no mutation (Figure 1E). In the wtsx1 egg chambers, when the posterior follicle cells were GFP-positive clones (wtsx1 clones) (Figure 1F,J), we observed that the OSK mis-localized to the middle of the oocyte (Figure 1G), and we also observed the over-proliferative phenotype (Figure 1H) and the accumulation of the NICD signal (Figure 1I). These results are consistent with those of previous studies [45,46]. We found that the signal of GFP in the wtsx1 PFCs was lower than other GFP-positive clones (Figure 1J), but the NICD signal accumulated in the wts-mutant PFCs. Hence, in order to mark the wtsx1 PFCs, we chose the NICD signal as a marker (the yellow line in Figure 1I). The over-proliferative phenotype is effectively framed by the yellow line (Figure 1H).

2.2. Cytoophidium Length and Number Are Decreased in wts-Mutant PFCs

To investigate whether the wtsx1 mutation affects CTPS cytoophidia assembly in PFCs, we used antibodies targeting the NICD and CTPS for the immunostaining of egg chambers. In the control egg chambers, cytoophidia were observed in germline cells and follicle cells (Figure 2A,D). The NICD signal localized at the apical side of the follicle cells (Figure 2B), and a layer of follicle cells surrounded the germline cells (Figure 2C). In the wtsx1 egg chambers shown in Figure 2F, the accumulated NICD signal is framed by a yellow line (Figure 2G) to mark the wtsx1 PFCs, and the over-proliferative phenotype was observed, as shown with the yellow line (Figure 2H). We compared the length of cytoophidia in the NICD accumulation area with a normal area (Figure 2I). Comparing the GFP-positive clones, which had no accumulated NICD, with the GFP-negative clones, we found that the length of cytoophidia had no difference (data no shown) in the wtsx1 egg chambers. An analysis revealed that the length of cytoophidia in the accumulated NICD was shorter compared to the adjacent cells (Figure 2K). By counting the numbers of cytoophidia and follicle cells, we found that the proportion of cytoophidium in the accumulated NICD PFCs was decreased compared to other GFP-positive clones and GFP-negative clones (Figure 2L).

2.3. Cytoophidium Length and Number Are Decreased in Hpo-Mutant PFCs

To confirm that the reduction in the cytoophidium length can indeed be regulated by the Hippo pathway, we generated FLP/FRT mitotic clones in the egg chamber using a truncating (hpoBF33) allele of hpo. In the control egg chambers (Figure 3A), the NICD signal (Figure 3B) and cytoophidium length (Figure 3D) had no significant differences between the GFP-positive and GFP-negative clones (Figure 3E). There was a layer of follicle cells surrounding the germline cells (Figure 3C). The GFP-positive clones indicated that the follicle cells expressed GFP but had no mutations.
In the hpoBF33 egg chambers (Figure 3F), the accumulated NICD signal is framed by the yellow line in Figure 3G. The over-proliferative phenotype was also observed in the hpo-mutant PFCs (Figure 3H). Furthermore, during the quantification of the cytoophidia length, we observed that the hpoBF33 resulted in a decrease in the cytoophidium length in the NICD accumulation area (Figure 3I,K) compared with the cytoophidia in other follicle cells. Similarly, the proportion of cytoophidium in accumulated NICD PFCs was decreased compared to the other GFP-positive clones and GFP-negative clones (Figure 3L).

2.4. Hpo Mutation Decreases Cytoophidium Length Even If CTPS Is Overexpressed

To investigate whether CTPS overexpression can reduce the cytoophidia length in the hpo mutant PFCs, we generated a stock containing the hpoBF33 mutation and UAS-CTPS-mCherry-HA. In the control with the CTPS overexpressed egg chamber (Figure 4A), the yellow lines shown in Figure 4A marked the GFP-positive clones, which overexpressed CTPS. The NICD signal localized at the apical side of the follicle cells (Figure 4B). The follicle cells surrounded the germline cells (Figure 4C). The length and abundance of cytoophidia increased in the GFP-positive clones (Figure 4D).
In hpoBF33 with CTPS overexpressed egg chambers (Figure 4F), the hpo mutant PFCs shown in 4G are framed by a yellow line based on the accumulated NICD signal. The over-proliferative phenotype was observed and is shown within the yellow line in Figure 4H. The cytoophidium length increased within the GFP-positive clones (Figure 4F,I). The GFP-positive follicle cells took hpo mutation and overexpressed CTPS (Figure 4J). Additionally, it is worth noting that the length of cytoophidia in the accumulated NICD clones was shorter than the that in the other GFP-positive clones (Figure 4I,K).

2.5. CTPS Knockdown Suppresses hpoBF33-Induced Excessive Proliferation

To investigate whether the CTPS is required for cell proliferation regulated by the Hippo pathway, we generated a stock containing hpoBF33 and UAS-CTPS-RNAi. Here, we chose the hpoBF33 egg chamber as a control (Figure 5A), and the surface matched the accumulated NICD signal (Figure 5A’–A’’’). In hpoBF33 with CTPS knockdown egg chambers (Figure 5B), we observed that the NICD signal accumulated in the hpoBF33 with CTPS knockdown PFCs (Figure 5B’). By comparing the volume of surface, we found that the NICD accumulated volume in the hpoBF33 with CTPS knockdown was smaller than that in the hpoBF33 egg chambers (Figure 5E). This result indicated that CTPS knockdown suppresses the over-proliferation induced by hpoBF33 mutation.

2.6. CTPS Overexpression Increases the Volume of NICD in Hpo Mutant PFCs

Although the hpoBF33 mutation still resulted in a reduction in the cytoophidium length in PFCs when the CTPS was overexpressed, we attempted to determine whether CTPS overexpression exacerbates over-proliferation associated with hpoBF33. In the hpoBF33 with CTPS overexpressed egg chamber (Figure 5C), the volume of NICD accumulation was observed, and it is marked in a light red surface in Figure 5C’’–C’’’. The quantification showed that CTPS overexpression increased the volume of NICD accumulated in hpoBF33 with CTPS-OE PFCs by comparing with the hpoBF33 egg chamber (Figure 5E).

2.7. CTPSH355A Overexpression Does Not Increase the Volume of NICD in Hpo Mutant PFCs

To investigate whether the cytoophidium structure affects cell proliferation controlled by the Hippo pathway, we generated a stock containing hpoBF33 and UAS-CTPSH355A-mCherry-HA. It is worth noting that the cytoophidium is depolymerized when the His355 is replaced by Alanine. The H355A mutation only affects polymerization, but not the enzymatic activity [22,48,49]. In hpoBF33 with CTPSH355A overexpressed egg chambers (Figure 5D), the GFP-positive clones took hpoBF33 mutation and overexpressed CTPSH355A. The quantification showed that the volume of NICD in hpoBF33 with CTPSH355A-OE had no significant difference compared with the hpoBF33 clones (Figure 5E). These results suggest that the cytoophidium structure contributes to the over-proliferative phenotype induced by the Hippo pathway.

3. Discussion

The Hippo pathway regulates cell proliferation and apoptosis. We found that mutations of wts and hpo decrease the length and number of cytoophidium in PFCs. A previous study found that the overexpression of dMyc promotes cytoophidium assembly and that the knockdown of dMyc reduces cytoophidium formation and the nucleus size in follicle cells [10]. The knockdown of dMyc downregulated CTPS expression in Drosophila cells [50]. The overexpression of active Ras increases the length and abundance of cytoophidia [11]. The overexpression of dMyc induces cell growth, and the overexpression of active Ras induces over-proliferation in Drosophila intestines. The cytoophidium length reduction phenotype induced by Hippo mutations differs from dMyc and Ras.
Cytophidium formation is related to the intracellular CTPS concentration, and the overexpression of CTPS promotes cytoophidium assembly and increases the CTP concentration [51]. The role of the Hippo pathway in the regulation of CTPS expression remains unclear. We hypothesize that the mutation of the Hippo pathway does not result in an abnormal expression of CTPS. CTPS cytoophidia inhibit enzyme activity in S. cerevisiae, Escherichia coli and D. melanogaster [9,51,52,53]. During stage 10a-b of oogenesis, the follicle cells grow rapidly and the number of cytoophidia is reduced [10]. Hence, we speculate that the CTPS cytoophidia may depolymerize to release more active CTPS for CTP synthesis in Hippo-mutant PFCs.
In Drosophila oogenesis, follicle cells are suitable for the study of cell proliferation. A previous study found that mutations in the Hippo pathway control the polarity of posterior follicle cells, and Dlg could be found all around the cell periphery in Hippo-mutant PFCs [46]. The cell polarity maintains the cytoophidia formation. The cytoophidia distribute in the basolateral side of follicle cells, and the absence of aPKC decreased the percentage of cells with cytoophidia [21]. Hence, the reduced proportion of cytoophidia in Hippo-mutant PFCs may be due to a disruption in the cell polarity.
In the future, we can further investigate whether CTPS expression is regulated by the Hippo pathway. Our study showed that over-proliferation was promoted when CTPS was overexpressed. The knockdown of CTPS suppressed the over-proliferation induced by the Hippo pathway mutation, indicating that CTPS plays a role in the regulation of cell proliferation by the Hippo pathway. Therefore, modulating the activity of metabolic enzymes may offer potential treatment options for cancer caused by Hippo mutations. Hence, it is possible to use 6-Diazo-5-oxo-L-norleucine (a CTPS inhibitor) [17,54] to target CTPS to suppress the over-proliferative phenotype induced by Hippo mutations.
In conclusion, our data demonstrate that the Hippo pathway regulates CTPS cytoophidium formation in Drosophila posterior follicle cells. Interestingly, when CTPS is overexpressed, the Hippo pathway still decreases the length of cytoophidia. Additionally, the knockdown of CTPS suppresses the over-proliferation caused by hpoBF33. Collectively, this study provides a novel insight into the research on Hippo-related cancer by establishing a connection between the Hippo pathway and CTPS cytoophidia.

4. Materials and Methods

4.1. Fly Stocks

All D. melanogaster stocks were maintained at 25 °C on standard cornmeal [55].
The MARCM system:
hsFlp; FRT42 tubulin-GAL80, tubulin-GAL4/Sp; UAS-GFP/Tm6B;
yw, hsFlp, UAS-GFP; FRT82B tubulin-GAL80, tubulin-GAL4/Tm6B;
yw; FRT42D hpoBF33/Cyo;
Control: yw; FRT42D/Cyo;
yw; FRT82B wtslatsX1/Tm6B;
Control: yw; FRT82B/Tm6B.
The transgenic RNAi line, UAS-CTPS-RNAi, was obtained from the TsingHua Fly Center, stock number THU2302. The homozygote UAS-CTPS-mCherry-HA in Chromosome III and the homozygote UAS-CTPSH355A-mCherry-HA in Chromosome III were constructed by our lab. If/Cyo; Sb/Tm6B was a gift from Yuu Kimata’s lab.
We generated HpoBF33/Cyo; UAS-CTPS-RNAi/Tm6B by crossing HpoBF33/Cyo with double balancer flies for two generations to construct HpoBF33/Cyo; Sb/Tm6B. UAS-CTPS-RNAi flies were crossed with double balancer flies for two generations to construct If/Cyo; UAS-CTPS-RNAi/Tm6B. Then, HpoBF33/Cyo; Sb/Tm6B were crossed with If/Cyo; UAS-CTPS-RNAi/Tm6B to obtain the HpoBF33/Cyo; UAS-CTPS-RNAi/Tm6B strain. The control strain, FRT42D/Cyo; UAS-CTPS-RNAi/Tm6B, was constructed using the same method.
We used the same method to construct the following stocks:
HpoBF33/Cyo; UAS-CTPS-mCherry-HA/Tm6B;
FRT42D/Cyo; UAS-CTPS-mCherry-HA/Tm6B;
HpoBF33/Cyo; UAS-CTPSH355A-mCherry-HA/Tm6B.

4.2. Immunohistochemistry

Female Drosophila were incubated for 3–5 days after pupation and dissected in at least three technical replicates. Each replicate contained more than five flies. Mosaic tissues were obtained with the FLP/FRT system with hsFLP drivers. The follicle cell clones were generated by the FRT/FLP recombinase with the presence of GFP as a marker for homozygous clones. For the loss of function, adult flies were heat-shocked for 1 h at 37 °C and heat shocked for 1 h at 37 °C at the third day, and then dissected 3 days after heat shock.
Ovaries from flies were dissected in Grace’s Insect Medium (Thermo Fisher, Rockford, IL, USA) and then fixed in 4% formaldehyde (10 μL of 40% formaldehyde (Sigma-Aldrich, Shanghai, China) diluted in 90 μL PBS) for 10 min before immunofluorescence staining.
The samples were then washed using PST (0.5% horse serum + 0.3% Triton X-100 in PBS) and incubated in PST for about 1 h to block. The samples were incubated in primary antibodies overnight at room temperature. Then, they were briefly rinsed with PST and incubated in secondary antibodies and Hoechst 33342 (1:5000; Thermo Fisher, Rockford, IL, USA) for two hours at room temperature.
Primary antibodies used in this study were rabbit anti-CTPS (1:1000; y-88, sc-134457, Santa Cruz BioTech Ltd., Santa Cruz, CA, USA), mouse anti-Notch (1:100, C17.9C6, Developmental Studies Hybridoma Bank, USA) and rabbit anti-Oskar (1:500). Secondary antibodies used in this study were goat anti-mouse Alexa Fluor® 594 nm (1:500, Invitrogen A11032), donkey anti-rabbit Cy3 (1:1000, Jackson 711-165-152), donkey anti-mouse Cy5 (1:1000, Jackson 715-005-151) and donkey anti-rabbit Cy5 (1:1000, Jackson 711-175-152).

4.3. Microscopy and Image Analysis

All images were obtained under a laser-scanning confocal microscope (Zeiss 980). Image processing was performed using Zeiss Zen (version 3.4). For each statistical quantification, we collected the images using Zeiss 980 with the interval as 0.5 μm for z-stack by using 40× objective, and more than 3 egg chambers were quantified per genotype (biological repeats = 3). Each view was processed for maximum intensity projection, and the length of cytoophidium length was analyzed using ImageJ version 1.43 U (downloaded from https://imagej.net/ij/index.html). The number of cytoophidia and cell nuclei were counted using multi-point tool in ImageJ [56]. To quantify over-proliferative phenotype, we chose the volume of accumulated NICD signal based on NICD accumulated in Hippo-mutant PFCs. The volume of accumulated NICD was boxed by the surface tool in Imaris x64 9.0.1. Representative images with maximum intensity projection are shown in all figures.

4.4. Data Analysis

Images collected using confocal microscopy were processed using Adobe Illustrator, ImageJ and Imaris x64 9.0.1. Quantitative analysis was processed using Excel (Version 2108) and GraphPad Prism 9. For all experiments, the data are represented as average ± SEM. Student’s t-test was performed to check for significant differences between data groups. In dot plots, a dot represents an egg chamber.

Author Contributions

R.-Y.W.: Conceptualization, Methodology, Investigation, Formal Analysis, Writing—Original Draft, and Visualization. L.Z.: Conceptualization, Resources, Writing—Review and Editing, Supervision, and Project Administration. J.-L.L.: Conceptualization, Resources, Writing—Review and Editing, Supervision, and Project Administration. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by National Natural Science Foundation of China (Grant Nos. 32370744 and 32350710195 to J.-L.L.) and UK Medical Research Council (Grant Nos. MC_UU_12021/3 and MC_U137788471 to J.-L.L.). The APC was funded by ShanghaiTech University.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

All data is available in the main text.

Acknowledgments

We thank the Molecular Imaging Core Facility (MICF) at the School of Life Science and Technology, ShanghaiTech University for providing technical support. We thank the Core Facility of Drosophila Resource and Technology. We also thank Huo-Yuan Liu for reading this manuscript.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Lieberman, I. Enzymatic amination of uridine triphosphate to cytidine triphosphate. J. Biol. Chem. 1956, 222, 765–775. [Google Scholar] [CrossRef] [PubMed]
  2. Levitzki, A.; Koshland, D.E., Jr. Cytidine triphosphate synthetase. Covalent intermediates and mechanisms of action. Biochemistry 1971, 10, 3365–3371. [Google Scholar] [CrossRef] [PubMed]
  3. Robertson, J.G. Determination of subunit dissociation constants in native and inactivated CTP synthetase by sedimentation equilibrium. Biochemistry 1995, 34, 7533–7541. [Google Scholar] [CrossRef] [PubMed]
  4. Levitzki, A.; Koshland, D.E., Jr. Ligand-induced dimer-to-tetramer transformation in cytosine triphosphate synthetase. Biochemistry 1972, 11, 247–253. [Google Scholar] [CrossRef] [PubMed]
  5. Williams, J.C.; Kizaki, H.; Weber, G.; Morris, H.P. Increased CTP synthetase activity in cancer cells. Nature 1978, 271, 71–73. [Google Scholar] [CrossRef]
  6. Liu, J.-L. Intracellular compartmentation of CTP synthase in Drosophila. J. Genet. Genom. 2010, 37, 281–296. [Google Scholar] [CrossRef]
  7. Noree, C.; Sato, B.K.; Broyer, R.M.; Wilhelm, J.E. Identification of novel filament-forming proteins in Saccharomyces cerevisiae and Drosophila melanogaster. J. Cell Biol. 2010, 190, 541–551. [Google Scholar] [CrossRef]
  8. Zhang, J.; Hulme, L.; Liu, J.L. Asymmetric inheritance of cytoophidia in Schizosaccharomyces pombe. Biol. Open 2014, 3, 1092–1097. [Google Scholar] [CrossRef]
  9. Carcamo, W.C.; Satoh, M.; Kasahara, H.; Terada, N.; Hamazaki, T.; Chan, J.Y.; Yao, B.; Tamayo, S.; Covini, G.; von Muhlen, C.A.; et al. Induction of cytoplasmic rods and rings structures by inhibition of the CTP and GTP synthetic pathway in mammalian cells. PLoS ONE 2011, 6, e29690. [Google Scholar] [CrossRef]
  10. Aughey, G.N.; Grice, S.J.; Liu, J.L. The Interplay between Myc and CTP Synthase in Drosophila. PLoS Genet. 2016, 12, e1005867. [Google Scholar] [CrossRef]
  11. Zhou, Y.; Liu, J.; Liu, J.L. Connecting Ras and CTP synthase in Drosophila. Exp. Cell Res. 2022, 416, 113155. [Google Scholar] [CrossRef] [PubMed]
  12. Sun, Z.; Liu, J.L. mTOR-S6K1 pathway mediates cytoophidium assembly. J. Genet. Genom. 2019, 46, 65–74. [Google Scholar] [CrossRef] [PubMed]
  13. Andreadis, C.; Hulme, L.; Wensley, K.; Liu, J.L. The TOR pathway modulates cytoophidium formation in Schizosaccharomyces pombe. J. Biol. Chem. 2019, 294, 14686–14703. [Google Scholar] [CrossRef] [PubMed]
  14. Wu, Z.; Liu, J.L. Cytoophidia respond to nutrient stress in Drosophila. Exp. Cell Res. 2019, 376, 159–167. [Google Scholar] [CrossRef]
  15. Chang, C.C.; Jeng, Y.M.; Peng, M.; Keppeke, G.D.; Sung, L.Y.; Liu, J.L. CTP synthase forms the cytoophidium in human hepatocellular carcinoma. Exp. Cell Res. 2017, 361, 292–299. [Google Scholar] [CrossRef] [PubMed]
  16. Zhang, Y.; Liu, J.; Liu, J.L. The atlas of cytoophidia in Drosophila larvae. J. Genet. Genom. 2020, 47, 321–331. [Google Scholar] [CrossRef] [PubMed]
  17. Chen, K.; Zhang, J.; Tastan, O.Y.; Deussen, Z.A.; Siswick, M.Y.; Liu, J.L. Glutamine analogs promote cytoophidium assembly in human and Drosophila cells. J. Genet. Genom. 2011, 38, 391–402. [Google Scholar] [CrossRef] [PubMed]
  18. Azzam, G.; Liu, J.L. Only one isoform of Drosophila melanogaster CTP synthase forms the cytoophidium. PLoS Genet. 2013, 9, e1003256. [Google Scholar] [CrossRef]
  19. Wang, P.Y.; Lin, W.C.; Tsai, Y.C.; Cheng, M.L.; Lin, Y.H.; Tseng, S.H.; Chakraborty, A.; Pai, L.M. Regulation of CTP Synthase Filament Formation During DNA Endoreplication in Drosophila. Genetics 2015, 201, 1511–1523. [Google Scholar] [CrossRef]
  20. Wang, Q.-Q.; You, D.-D.; Liu, J.-L. Cytoophidia Maintain the Integrity of Drosophila Follicle Epithelium. Int. J. Mol. Sci. 2022, 23, 15282. [Google Scholar] [CrossRef]
  21. Wang, Q.Q.; Zhao, P.A.; Tastan, O.Y.; Liu, J.L. Polarised maintenance of cytoophidia in Drosophila follicle epithelia. Exp. Cell Res. 2021, 402, 112564. [Google Scholar] [CrossRef] [PubMed]
  22. Liu, J.; Zhang, Y.; Zhou, Y.; Wang, Q.Q.; Ding, K.; Zhao, S.; Lu, P.; Liu, J.L. Cytoophidia coupling adipose architecture and metabolism. Cell Mol. Life Sci. 2022, 79, 534. [Google Scholar] [CrossRef] [PubMed]
  23. Sun, Z.; Liu, J.L. Forming cytoophidia prolongs the half-life of CTP synthase. Cell Discov. 2019, 5, 32. [Google Scholar] [CrossRef] [PubMed]
  24. Justice, R.W.; Zilian, O.; Woods, D.F.; Noll, M.; Bryant, P.J. The Drosophila tumor suppressor gene warts encodes a homolog of human myotonic dystrophy kinase and is required for the control of cell shape and proliferation. Genes. Dev. 1995, 9, 534–546. [Google Scholar] [CrossRef] [PubMed]
  25. Xu, T.; Wang, W.; Zhang, S.; Stewart, R.A.; Yu, W. Identifying tumor suppressors in genetic mosaics: The Drosophila lats gene encodes a putative protein kinase. Development 1995, 121, 1053–1063. [Google Scholar] [CrossRef] [PubMed]
  26. Wu, S.; Huang, J.; Dong, J.; Pan, D. hippo encodes a Ste-20 family protein kinase that restricts cell proliferation and promotes apoptosis in conjunction with salvador and warts. Cell 2003, 114, 445–456. [Google Scholar] [CrossRef] [PubMed]
  27. Tapon, N.; Harvey, K.F.; Bell, D.W.; Wahrer, D.C.; Schiripo, T.A.; Haber, D.; Hariharan, I.K. salvador Promotes both cell cycle exit and apoptosis in Drosophila and is mutated in human cancer cell lines. Cell 2002, 110, 467–478. [Google Scholar] [CrossRef] [PubMed]
  28. Lai, Z.C.; Wei, X.; Shimizu, T.; Ramos, E.; Rohrbaugh, M.; Nikolaidis, N.; Ho, L.L.; Li, Y. Control of cell proliferation and apoptosis by mob as tumor suppressor, mats. Cell 2005, 120, 675–685. [Google Scholar] [CrossRef]
  29. Oh, H.; Irvine, K.D. In vivo analysis of Yorkie phosphorylation sites. Oncogene 2009, 28, 1916–1927. [Google Scholar] [CrossRef]
  30. Badouel, C.; McNeill, H. SnapShot: The hippo signaling pathway. Cell 2011, 145, 484.e1. [Google Scholar] [CrossRef]
  31. Pan, D. The hippo signaling pathway in development and cancer. Dev. Cell 2010, 19, 491–505. [Google Scholar] [CrossRef] [PubMed]
  32. Meng, Z.; Moroishi, T.; Guan, K.L. Mechanisms of Hippo pathway regulation. Genes. Dev. 2016, 30, 1–17. [Google Scholar] [CrossRef] [PubMed]
  33. Harvey, K.F.; Pfleger, C.M.; Hariharan, I.K. The Drosophila Mst Ortholog, hippo, Restricts Growth and Cell Proliferation and Promotes Apoptosis. Cell 2003, 114, 457–467. [Google Scholar] [CrossRef] [PubMed]
  34. Koo, J.H.; Guan, K.L. Interplay between YAP/TAZ and Metabolism. Cell Metab. 2018, 28, 196–206. [Google Scholar] [CrossRef]
  35. Murakami, H.; Mizuno, T.; Taniguchi, T.; Fujii, M.; Ishiguro, F.; Fukui, T.; Akatsuka, S.; Horio, Y.; Hida, T.; Kondo, Y.; et al. LATS2 is a tumor suppressor gene of malignant mesothelioma. Cancer Res. 2011, 71, 873–883. [Google Scholar] [CrossRef]
  36. Noh, M.G.; Kim, S.S.; Hwang, E.C.; Kwon, D.D.; Choi, C. Yes-Associated Protein Expression Is Correlated to the Differentiation of Prostate Adenocarcinoma. J. Pathol. Transl. Med. 2017, 51, 365–373. [Google Scholar] [CrossRef]
  37. Cox, A.G.; Hwang, K.L.; Brown, K.K.; Evason, K.; Beltz, S.; Tsomides, A.; O’Connor, K.; Galli, G.G.; Yimlamai, D.; Chhangawala, S.; et al. Yap reprograms glutamine metabolism to increase nucleotide biosynthesis and enable liver growth. Nat. Cell Biol. 2016, 18, 886–896. [Google Scholar] [CrossRef]
  38. Ali, E.S.; Ben-Sahra, I. Regulation of nucleotide metabolism in cancers and immune disorders. Trends Cell Biol. 2023, 33, 950–966. [Google Scholar] [CrossRef]
  39. Santinon, G.; Brian, I.; Pocaterra, A.; Romani, P.; Franzolin, E.; Rampazzo, C.; Bicciato, S.; Dupont, S. dNTP metabolism links mechanical cues and YAP/TAZ to cell growth and oncogene-induced senescence. EMBO J. 2018, 37, e97780. [Google Scholar] [CrossRef]
  40. Bischof, J.; Basler, K. Recombinases and their use in gene activation, gene inactivation, and transgenesis. Methods Mol. Biol. 2008, 420, 175–195. [Google Scholar] [CrossRef]
  41. Riechmann, V.; Ephrussi, A. Axis formation during Drosophila oogenesis. Curr. Opin. Genet. Dev. 2001, 11, 374–383. [Google Scholar] [CrossRef]
  42. van Eeden, F.; St Johnston, D. The polarisation of the anterior-posterior and dorsal-ventral axes during Drosophila oogenesis. Curr. Opin. Genet. Dev. 1999, 9, 396–404. [Google Scholar] [CrossRef] [PubMed]
  43. St Johnston, D. Moving messages: The intracellular localization of mRNAs. Nat. Rev. Mol. Cell Biol. 2005, 6, 363–375. [Google Scholar] [CrossRef] [PubMed]
  44. González-Reyes, A.; Elliott, H.; St Johnston, D. Polarization of both major body axes in Drosophila by gurken-torpedo signalling. Nature 1995, 375, 654–658. [Google Scholar] [CrossRef] [PubMed]
  45. Meignin, C.; Alvarez-Garcia, I.; Davis, I.; Palacios, I.M. The salvador-warts-hippo pathway is required for epithelial proliferation and axis specification in Drosophila. Curr. Biol. 2007, 17, 1871–1878. [Google Scholar] [CrossRef]
  46. Polesello, C.; Tapon, N. Salvador-warts-hippo signaling promotes Drosophila posterior follicle cell maturation downstream of notch. Curr. Biol. 2007, 17, 1864–1870. [Google Scholar] [CrossRef]
  47. Wu, J.S.; Luo, L. A protocol for mosaic analysis with a repressible cell marker (MARCM) in Drosophila. Nat. Protoc. 2006, 1, 2583–2589. [Google Scholar] [CrossRef]
  48. Chang, C.C.; Keppeke, G.D.; Antos, C.L.; Peng, M.; Andrade, L.E.C.; Sung, L.Y.; Liu, J.L. CTPS forms the cytoophidium in zebrafish. Exp. Cell Res. 2021, 405, 112684. [Google Scholar] [CrossRef]
  49. Simonet, J.C.; Foster, M.J.; Lynch, E.M.; Kollman, J.M.; Nicholas, E.; O’Reilly, A.M.; Peterson, J.R. CTP synthase polymerization in germline cells of the developing Drosophila egg supports egg production. Biol. Open 2020, 9, bio050328. [Google Scholar] [CrossRef]
  50. Hulf, T.; Bellosta, P.; Furrer, M.; Steiger, D.; Svensson, D.; Barbour, A.; Gallant, P. Whole-genome analysis reveals a strong positional bias of conserved dMyc-dependent E-boxes. Mol. Cell Biol. 2005, 25, 3401–3410. [Google Scholar] [CrossRef]
  51. Aughey, G.N.; Grice, S.J.; Shen, Q.J.; Xu, Y.; Chang, C.C.; Azzam, G.; Wang, P.Y.; Freeman-Mills, L.; Pai, L.M.; Sung, L.Y.; et al. Nucleotide synthesis is regulated by cytoophidium formation during neurodevelopment and adaptive metabolism. Biol. Open 2014, 3, 1045–1056. [Google Scholar] [CrossRef] [PubMed]
  52. Barry, R.M.; Bitbol, A.F.; Lorestani, A.; Charles, E.J.; Habrian, C.H.; Hansen, J.M.; Li, H.J.; Baldwin, E.P.; Wingreen, N.S.; Kollman, J.M.; et al. Large-scale filament formation inhibits the activity of CTP synthetase. Elife 2014, 3, e03638. [Google Scholar] [CrossRef] [PubMed]
  53. Noree, C.; Monfort, E.; Shiau, A.K.; Wilhelm, J.E. Common regulatory control of CTP synthase enzyme activity and filament formation. Mol. Biol. Cell 2014, 25, 2282–2290. [Google Scholar] [CrossRef] [PubMed]
  54. Zhou, X.; Guo, C.-J.; Chang, C.-C.; Zhong, J.; Hu, H.-H.; Lu, G.-M.; Liu, J.-L. Structural basis for ligand binding modes of CTP synthase. Proc. Natl. Acad. Sci. USA 2021, 118, e2026621118. [Google Scholar] [CrossRef]
  55. Xu, L.M.; Shen, Y.; Wu, W. Preparation of the Flies // Embryo Manipulation Manual of Laboratory Animals. Bio-101 2023, e1010975. [Google Scholar] [CrossRef]
  56. Zhang, S.; Li, H.; Liu, J.L. Long-Term Imaging and Dynamic Analysis of Cytoophidia in Yeast. Methods Mol. Biol. 2021, 2196, 235–244. [Google Scholar] [CrossRef]
Figure 1. Wts is required for oocyte polarity. (AE) The Oskar (OSK, red in (A), white in (B)) protein localizes at the posterior crescent of the stage-9 FRT82B control oocyte. The Notch intercellular domain (NICD, white in (A,D) labels the Notch signal and is located in the membrane of the follicle cells and germline cells. Recombinant cells are marked with GFP, and the GFP-positive clones express GFP but have no mutation (green in (A), white in (E)). (FJ) When wts mutates in posterior follicle cells, OSK (red in (F), white in (G)) relocates to the middle of the stage-9 oocyte. The wts mutant posterior follicle cells show an over-proliferative phenotype and an accumulation of NICD (white in (F,I)). DNA is stained with Hoechst 33342 (blue in (F), white in (H)). Recombinant cells are marked with GFP, and GFP-positive clones take wtsx1 mutation (green in (F), white in (J)). Scale bars, 20 μm.
Figure 1. Wts is required for oocyte polarity. (AE) The Oskar (OSK, red in (A), white in (B)) protein localizes at the posterior crescent of the stage-9 FRT82B control oocyte. The Notch intercellular domain (NICD, white in (A,D) labels the Notch signal and is located in the membrane of the follicle cells and germline cells. Recombinant cells are marked with GFP, and the GFP-positive clones express GFP but have no mutation (green in (A), white in (E)). (FJ) When wts mutates in posterior follicle cells, OSK (red in (F), white in (G)) relocates to the middle of the stage-9 oocyte. The wts mutant posterior follicle cells show an over-proliferative phenotype and an accumulation of NICD (white in (F,I)). DNA is stained with Hoechst 33342 (blue in (F), white in (H)). Recombinant cells are marked with GFP, and GFP-positive clones take wtsx1 mutation (green in (F), white in (J)). Scale bars, 20 μm.
Ijms 25 01453 g001
Figure 2. Wtsx1 decreases cytoophidium length and number in wts mutant PFCs. (AE) In the FRT82B control egg chamber, there is no difference in the NICD signal (red in (A), white in (B)) or the nuclear size (blue in (A), white in (C)) of follicle cells between GFP-positive (green in (A), white in (E)) and GFP-negative clones. Cytoophidia labeled with CTPS (white in (A,D)) exist in follicle cells and germline cells. There is no difference in cytoophidium length between GFP-positive and GFP-negative clones. Recombinant cells are marked with GFP and have no mutation. (FJ) In wtsx1 egg chamber, NICD (red in (F), white in (G)) accumulates in posterior follicle cells (yellow line in (G)). After wtsx1 mutation, the length of cytoophidia (white in (F,I)) in posterior follicle cells is decreased, while the number of cells increases. DNA is stained with Hoechst 33342 (blue in (F), white in (H)). Recombinant cells are marked with GFP (green in (F), white in (J)) and take wtsx1 mutation. Scale bars, 20 μm. (K) Quantification shows that wtsx1 decreases the cytoophidium length in posterior follicle cells. **** p < 0.0001, ns = not significant, mean shown with SED (Student’s t test). (L) Quantification shows that wtsx1 decreases the number of cytoophidium in posterior follicle cells. **** p < 0.0001, ns = not significant, mean shown with SED (Student’s t-test).
Figure 2. Wtsx1 decreases cytoophidium length and number in wts mutant PFCs. (AE) In the FRT82B control egg chamber, there is no difference in the NICD signal (red in (A), white in (B)) or the nuclear size (blue in (A), white in (C)) of follicle cells between GFP-positive (green in (A), white in (E)) and GFP-negative clones. Cytoophidia labeled with CTPS (white in (A,D)) exist in follicle cells and germline cells. There is no difference in cytoophidium length between GFP-positive and GFP-negative clones. Recombinant cells are marked with GFP and have no mutation. (FJ) In wtsx1 egg chamber, NICD (red in (F), white in (G)) accumulates in posterior follicle cells (yellow line in (G)). After wtsx1 mutation, the length of cytoophidia (white in (F,I)) in posterior follicle cells is decreased, while the number of cells increases. DNA is stained with Hoechst 33342 (blue in (F), white in (H)). Recombinant cells are marked with GFP (green in (F), white in (J)) and take wtsx1 mutation. Scale bars, 20 μm. (K) Quantification shows that wtsx1 decreases the cytoophidium length in posterior follicle cells. **** p < 0.0001, ns = not significant, mean shown with SED (Student’s t test). (L) Quantification shows that wtsx1 decreases the number of cytoophidium in posterior follicle cells. **** p < 0.0001, ns = not significant, mean shown with SED (Student’s t-test).
Ijms 25 01453 g002
Figure 3. HpoBF33 decreases cytoophidium length and number in hpo mutant PFCs. (AE) In the FRT42D control egg chamber, there is no difference in the NICD signal (red in (A), white in (B)) and the nuclear size (blue in (A), white in (C)) of follicle cells between GFP-positive and GFP-negative clones. Cytoophidia labeled with CTPS (white in (A,D)) exist in follicle cells and germline cells. There is no difference in cytoophidium length between GFP-positive and GFP-negative clones. Recombinant cells are marked with GFP and have no mutation (green in (A), white in (E)). (FJ) In the hpoBF33 egg chamber, NICD (red in (F), white in (G)) accumulates in posterior follicle cells (yellow line in (G)). After hpoBF33 mutation, the length of cytoophidia in posterior follicle cells is decreased, while the number of cells increases. DNA is stained with Hoechst 33342 (blue in (F), white in (H)). Recombinant cells are marked with GFP (green in (F), white in (J)) and take hpoBF33 mutation. Scale bars, 20 μm. (K) Quantification shows that the hpoBF33 decreases the cytoophidium length in posterior follicle cells. **** p < 0.0001, ns = not significant, mean shown with SED (Student’s t test). (L) Quantification shows that hpoBF33 decreases the number of cytoophidium in posterior follicle cells. *** p < 0.001, ns = not significant, mean shown with SED (Student’s t-test).
Figure 3. HpoBF33 decreases cytoophidium length and number in hpo mutant PFCs. (AE) In the FRT42D control egg chamber, there is no difference in the NICD signal (red in (A), white in (B)) and the nuclear size (blue in (A), white in (C)) of follicle cells between GFP-positive and GFP-negative clones. Cytoophidia labeled with CTPS (white in (A,D)) exist in follicle cells and germline cells. There is no difference in cytoophidium length between GFP-positive and GFP-negative clones. Recombinant cells are marked with GFP and have no mutation (green in (A), white in (E)). (FJ) In the hpoBF33 egg chamber, NICD (red in (F), white in (G)) accumulates in posterior follicle cells (yellow line in (G)). After hpoBF33 mutation, the length of cytoophidia in posterior follicle cells is decreased, while the number of cells increases. DNA is stained with Hoechst 33342 (blue in (F), white in (H)). Recombinant cells are marked with GFP (green in (F), white in (J)) and take hpoBF33 mutation. Scale bars, 20 μm. (K) Quantification shows that the hpoBF33 decreases the cytoophidium length in posterior follicle cells. **** p < 0.0001, ns = not significant, mean shown with SED (Student’s t test). (L) Quantification shows that hpoBF33 decreases the number of cytoophidium in posterior follicle cells. *** p < 0.001, ns = not significant, mean shown with SED (Student’s t-test).
Ijms 25 01453 g003
Figure 4. Even if CTPS is overexpressed, the hpoBF33 decreases cytoophidium length in PFCs. (AE) In the FRT42D with CTPS overexpression egg chamber, there is no difference in the NICD signal (white in (A,B)) of follicle cells between GFP-positive (green in (A), white in I) and GFP-negative clones. The length and number of cytoophidia labeled with CTPS (red in (A), white in (D)) increase in the GFP-positive follicle cells. DNA is stained with Hoechst 33342 (blue in (A), white in (C)). The GFP-positive clones are marked by yellow line. (FJ) In the hpo mutant with CTPS overexpression, NICD (white in (F,G)) accumulates in posterior follicle cells (yellow box in (F)). After hpoBF33 mutated, the length of cytoophidium in posterior follicle cells (yellow box in (I)) is shorter than those in other GFP-positive regions. DNA is stained with Hoechst 33342 (blue in (F), white in (H)). Recombinant cells are marked with GFP (green in (F), white in (J)) and take hpoBF33 mutation and CTPS overexpression. Scale bars, 25 μm. (K) Quantification shows that hpoBF33 mutation decreased the cytoophidium length in posterior follicle cells, even if CTPS was overexpressed. **** p < 0.0001, mean shown with SED (Student’s t-test).
Figure 4. Even if CTPS is overexpressed, the hpoBF33 decreases cytoophidium length in PFCs. (AE) In the FRT42D with CTPS overexpression egg chamber, there is no difference in the NICD signal (white in (A,B)) of follicle cells between GFP-positive (green in (A), white in I) and GFP-negative clones. The length and number of cytoophidia labeled with CTPS (red in (A), white in (D)) increase in the GFP-positive follicle cells. DNA is stained with Hoechst 33342 (blue in (A), white in (C)). The GFP-positive clones are marked by yellow line. (FJ) In the hpo mutant with CTPS overexpression, NICD (white in (F,G)) accumulates in posterior follicle cells (yellow box in (F)). After hpoBF33 mutated, the length of cytoophidium in posterior follicle cells (yellow box in (I)) is shorter than those in other GFP-positive regions. DNA is stained with Hoechst 33342 (blue in (F), white in (H)). Recombinant cells are marked with GFP (green in (F), white in (J)) and take hpoBF33 mutation and CTPS overexpression. Scale bars, 25 μm. (K) Quantification shows that hpoBF33 mutation decreased the cytoophidium length in posterior follicle cells, even if CTPS was overexpressed. **** p < 0.0001, mean shown with SED (Student’s t-test).
Ijms 25 01453 g004
Figure 5. CTPS plays a role in the over-proliferative phenotype in hpoBF33 mutant PFCs. (AA’’’) In the 3D view of hpoBF33 mutant egg chamber, NICD (red in (A,A’)) accumulates in posterior follicle cells (light red box in (A’’,A’’’)). The merged image shows the surface within the accumulated NICD signal. (BB’’’) In the 3D view of hpoBF33 with CTPS knockdown, NICD (red in (B,B’)) accumulates in posterior follicle cells (light red in (B’’,B’’’)). The merged image shows the surface within the accumulated NICD signal. (CC’’’) In the 3D view of hpoBF33 with CTPS overexpression, NICD (red in (C,C’)) accumulates in posterior follicle cells (light red in (C’’,C’’’)). The merged image shows the surface within the accumulated NICD signal. (DD’’’) In the 3D view of hpoBF33 with CTPSH355A overexpression, NICD (red in (D,D’)) accumulates in posterior follicle cells (light red in (D’’,D’’’)). The merged image shows the surface within the accumulated NICD signal. Scale bars, 20 μm. (E) Quantification shows that CTPS overexpression promotes the volume of over-proliferative phenotype in hpoBF33 PFCs. CTPS knockdown inhibits the volume of over-proliferative phenotype in hpoBF33 PFCs. CTPSH355A overexpression has no difference with hpoBF33 egg chambers in the volume of accumulated NICD signal. ** p < 0.01, *** p < 0.001, ns = not significant, mean shown with SED (Student’s t-test).
Figure 5. CTPS plays a role in the over-proliferative phenotype in hpoBF33 mutant PFCs. (AA’’’) In the 3D view of hpoBF33 mutant egg chamber, NICD (red in (A,A’)) accumulates in posterior follicle cells (light red box in (A’’,A’’’)). The merged image shows the surface within the accumulated NICD signal. (BB’’’) In the 3D view of hpoBF33 with CTPS knockdown, NICD (red in (B,B’)) accumulates in posterior follicle cells (light red in (B’’,B’’’)). The merged image shows the surface within the accumulated NICD signal. (CC’’’) In the 3D view of hpoBF33 with CTPS overexpression, NICD (red in (C,C’)) accumulates in posterior follicle cells (light red in (C’’,C’’’)). The merged image shows the surface within the accumulated NICD signal. (DD’’’) In the 3D view of hpoBF33 with CTPSH355A overexpression, NICD (red in (D,D’)) accumulates in posterior follicle cells (light red in (D’’,D’’’)). The merged image shows the surface within the accumulated NICD signal. Scale bars, 20 μm. (E) Quantification shows that CTPS overexpression promotes the volume of over-proliferative phenotype in hpoBF33 PFCs. CTPS knockdown inhibits the volume of over-proliferative phenotype in hpoBF33 PFCs. CTPSH355A overexpression has no difference with hpoBF33 egg chambers in the volume of accumulated NICD signal. ** p < 0.01, *** p < 0.001, ns = not significant, mean shown with SED (Student’s t-test).
Ijms 25 01453 g005
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Weng, R.-Y.; Zhang, L.; Liu, J.-L. Connecting Hippo Pathway and Cytoophidia in Drosophila Posterior Follicle Cells. Int. J. Mol. Sci. 2024, 25, 1453. https://doi.org/10.3390/ijms25031453

AMA Style

Weng R-Y, Zhang L, Liu J-L. Connecting Hippo Pathway and Cytoophidia in Drosophila Posterior Follicle Cells. International Journal of Molecular Sciences. 2024; 25(3):1453. https://doi.org/10.3390/ijms25031453

Chicago/Turabian Style

Weng, Rui-Yu, Lei Zhang, and Ji-Long Liu. 2024. "Connecting Hippo Pathway and Cytoophidia in Drosophila Posterior Follicle Cells" International Journal of Molecular Sciences 25, no. 3: 1453. https://doi.org/10.3390/ijms25031453

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop